<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">CC</journal-id><journal-title-group><journal-title>Computational Chemistry</journal-title></journal-title-group><issn pub-type="epub">2332-5968</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/cc.2019.72004</article-id><article-id pub-id-type="publisher-id">CC-91997</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Chemistry&amp;Materials Science</subject></subj-group></article-categories><title-group><article-title>
 
 
  Computation of Structure Activity and Design of Chalcone Derivatives
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yan</surname><given-names>Jiang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Qi</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Shuping</surname><given-names>Zhang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>College of Science, University of Shanghai for Science and Technology, Shanghai, China</addr-line></aff><pub-date pub-type="epub"><day>22</day><month>04</month><year>2019</year></pub-date><volume>07</volume><issue>02</issue><fpage>51</fpage><lpage>58</lpage><history><date date-type="received"><day>17,</day>	<month>December</month>	<year>2018</year></date><date date-type="rev-recd"><day>21,</day>	<month>April</month>	<year>2019</year>	</date><date date-type="accepted"><day>24,</day>	<month>April</month>	<year>2019</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Based on the antitumor activity of chalcone derivatives and their structure, the structure-activity relationship of chalcone derivatives was analyzed by CoMFA (comparative molecular field analysis) method and then the 3D-QSAR (the three dimensional quantitative structures activity relationship) model was established. The analytical results showed that the model had good stability and prediction ability with cross-validated Q
  <sup>2</sup> and non-cross-validated R
  <sup>2</sup> values of 0.527 and 0.995, respectively. The contour map of the model explained the relationship between the structure of chalcone derivatives and antitumor activity, and could be analyzed to design antitumor chalcone derivatives. We designed some structure of chalcone derivatives and calculated their antitumor activity. In this paper, 24 chalcone derivatives were studied by CoMFA, 3D-QSAR, molecular design, which provided theoretical for designing good activities chalcone derivatives.
 
</p></abstract><kwd-group><kwd>Three Dimensional-Quantitative Structures Activity Relationship</kwd><kwd> Chalcone Derivatives</kwd><kwd> Comparative Molecular Field Analysis</kwd><kwd> Antitumor Activity</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>A series of chalcone derivatives were synthesized according to their physiological activities, such as anti-inflammatory [<xref ref-type="bibr" rid="scirp.91997-ref1">1</xref>] , antiviral [<xref ref-type="bibr" rid="scirp.91997-ref2">2</xref>] , antitumor [<xref ref-type="bibr" rid="scirp.91997-ref3">3</xref>] , anticancer [<xref ref-type="bibr" rid="scirp.91997-ref4">4</xref>] and so on. The chalcone derivatives have different molecular structure and function and combine with different receptors. Now the tumor becomes a serious disease that endangers human health. The International Agency for Research on Cancer (IARC) released the latest estimate on the global burden of cancer and the report displayed that the global cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. In recent years, a number of studies have shown that chalcone derivatives could inhibit the growth of tumor [<xref ref-type="bibr" rid="scirp.91997-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.91997-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.91997-ref7">7</xref>] . For example, Sapavat Madhavi [<xref ref-type="bibr" rid="scirp.91997-ref8">8</xref>] synthesized a kind of anticancer drug which was based on the structure of chalcone. Bruna Lannuce Silva Cabral [<xref ref-type="bibr" rid="scirp.91997-ref9">9</xref>] and others have synthesized a new chalcone derivative LQFM064, which could induce the death of breast cancer cells.</p><p>There are many chalcone derivatives and these derivatives have long research and development cycle. In order to reduce the time of the research and development, the QSAR was used to study the relationship between the structure of chalcone and antitumor activity. Lots of studies have shown that 3D-QSAR was widely used in many compounds and their derivatives and provided a new idea for design of new derivatives [<xref ref-type="bibr" rid="scirp.91997-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.91997-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.91997-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.91997-ref13">13</xref>] . For example, Hui Zhi [<xref ref-type="bibr" rid="scirp.91997-ref14">14</xref>] studied on triazole derivatives as sglt inhibitors via CoMFA, and on the basis of the model, 8 new sglt inhibitors were designed and predicted. Xin Zhang and Hui Zhang [<xref ref-type="bibr" rid="scirp.91997-ref15">15</xref>] generated predictive 3D-QSAR model for modified design of Dopamine D3 receptor antagonists via CoMFA .</p><p>In this study, we used the SYBYL2.0 to establish the CoMFA model to research about the 3D-QSAR of 24 chalcone derivatives. And then according to the result of the model, we design two new chalcone derivatives. We expect that our work could provide complementary and useful information to design novel chalcone derivatives and predict their antitumor activity.</p></sec><sec id="s2"><title>2. Research Methods</title><sec id="s2_1"><title>2.1. Data Resources</title><p>The data we used was taken from the paper [<xref ref-type="bibr" rid="scirp.91997-ref16">16</xref>] . The structures of chalcone derivatives used in this study were listed in <xref ref-type="table" rid="table1">Table 1</xref> and their biological activity IC<sub>50</sub> (half maximal inhibitory concentration) values &#181;M (for inhibitor of the human colon cancer). The IC<sub>50</sub> was used as a dependent variable in the QSAR study and all original IC<sub>50</sub> values were converted to negative logarithm of IC<sub>50</sub> (pIC<sub>50</sub>). These data were importantly used to establish a 3D-QSAR model to observe the structure-activity relationship of chalcone derivatives.</p></sec><sec id="s2_2"><title>2.2. Comparative Molecular Field Analysis (CoMFA)</title><p>Molecular similarity searching is fast becoming a key tool in drug design. CoMFA is a method that reflects the non-bonding interaction between the receptor and the ligand [<xref ref-type="bibr" rid="scirp.91997-ref17">17</xref>] . CoMFA, analyses the relationship of compounds’ structure and activity, is widely used in drug design. The results of statistical analysis can be graphically outputted on the molecular surface to indicate steric and electrostatic properties, and can help understand the detail of interaction between the ligand and the active site of recepotir [<xref ref-type="bibr" rid="scirp.91997-ref18">18</xref>] .</p></sec><sec id="s2_3"><title>2.3. Model Establishment</title><p>First, molecular alignment is an important step in CoMFA operation, directly affects the predictive ability of the CoMFA model. In this study, 20 chalcone derivatives were used as the training sets and 4 chalcone derivatives were used as the test sets. The data sets were used to construct 3D-QSAR model and analysis their physicochemical properties. The most active chalcone compound 21 was selected as a common skeleton which was selected for the alignment of training molecules. As shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>, it’s compound 21 and shows the selected common skeleton. <xref ref-type="fig" rid="fig2">Figure 2</xref> shows the result of compounds of training sets aligned.</p><p><xref ref-type="table" rid="table1">Table 1</xref>. Chalcone derivatives and their experimental and predicted IC<sub>50</sub>.</p><disp-formula id="scirp.91997-formula1"><graphic  xlink:href="//html.scirp.org/file/2-1710109x2.png"  xlink:type="simple"/></disp-formula><p><img src="//html.scirp.org/file/2-1710109x4.png" /><img src="//html.scirp.org/file/2-1710109x3.png" /></p><p>*test data sets.</p></sec></sec><sec id="s3"><title>3. Results and Discussion</title><p>The analysis results of the chalcone derivatives model show in <xref ref-type="table" rid="table2">Table 2</xref>. The Q<sup>2</sup>, cross validation coefficient of the model is 0.6, which indicates that the model has the predictive ability. In addition, the calculational R<sup>2</sup><sub>pred</sub>. value of the test set is 0.978 by using Matlab software, which also indicates the model has good predictive ability. The R<sup>2</sup>, correlation coefficient of non cross validation is 0.997, which indicates the statistical stability of the model is good. The standard deviation is 0.017 and the variance ratio is 388. The contributions of the steric and electrostatic fields are 65.7% and 34.3% respectively, which indicates that the steric and electrostatic effects of molecules contribute to the molecular activity. The contribution of the steric field is better than the contribution of electrostatic field.</p><sec id="s3_1"><title>3.1. Model Validation of CoMFA</title><p><xref ref-type="fig" rid="fig3">Figure 3</xref> shows the correlation between the experimental value from the literature [<xref ref-type="bibr" rid="scirp.91997-ref16">16</xref>] and the predicted value of chalcone CoMFA model. As shown in the picture, the abscissa represents the experimental value, the ordinate represents the predicted value, the black points represents the training set and the red points represents the test set. And all the samples are concentrated near the line y = x, which indicates that the model has better fitting ability and predictive ability and the predicted value of model was similar to the experimental value.</p></sec><sec id="s3_2"><title>3.2. Analysis of the Countour Map</title><p>The countour map of chalcone is used to represent the steric and electrostatic fields of 24 compounds in different colors, as shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>. <xref ref-type="fig" rid="fig4">Figure 4</xref>(a) shows steric interactions by green and yellow colored contours. The green regions indicate that the bulky substituents are favored, and yellow regions increase activity with small volume substituents. <xref ref-type="fig" rid="fig4">Figure 4</xref>(b) shows electrostatic interactions by red and blue colored contours. The blue regions indicate that positive charges are favored, and red regions increase activity only with negative charges.</p><p>There is major green region around R<sub>2</sub> position in the steric contour map suggesting that a bulky group is preferred in the position to produce higher</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Statistical results of the CoMFA model</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Model</th><th align="center" valign="middle" >Q<sup>2</sup></th><th align="center" valign="middle" >R<sup>2</sup></th><th align="center" valign="middle" >S<sub>CV</sub></th><th align="center" valign="middle" >F</th><th align="center" valign="middle" >ONC</th><th align="center" valign="middle"  colspan="2"  >Fraction</th></tr></thead><tr><td align="center" valign="middle"  rowspan="2"  >CoMFA</td><td align="center" valign="middle"  rowspan="2"  >0.6</td><td align="center" valign="middle"  rowspan="2"  >0.997</td><td align="center" valign="middle"  rowspan="2"  >0.017</td><td align="center" valign="middle"  rowspan="2"  >388</td><td align="center" valign="middle"  rowspan="2"  >9</td><td align="center" valign="middle" >Ster</td><td align="center" valign="middle" >Elec</td></tr><tr><td align="center" valign="middle" >0.657</td><td align="center" valign="middle" >0.343</td></tr></tbody></table></table-wrap><p>Q<sup>2</sup>.: Cross-validated correlation coefficient. ONC.: Optimum number of components. R<sup>2</sup>: Non-cross- validated correlation coefficient. S<sub>cv</sub>.: Standard error of the estimate. F: test value.</p><p>antitumor activity. For example, 9 compounds (3 - 11) have higher antitumor activity than compound 2, because a mono-halogen and mono-methyl groups have bulky volume than hydrogen. An analysis that a relatively bulky substituent is beneficial to the antitumor activity. The electrostatic contour map shows a blue region surrounding the R<sub>2</sub> position, indicating that substituting which can increase the positive charge on the ring systems would result in better activity. It is found that an electron-withdrawing group like a mono-halogen increases the antitumor activity, such as compounds (3 - 8, 17 - 19). An analysis that a relatively electron-withdrawing substituent is beneficial to the antitumor activity.</p></sec><sec id="s3_3"><title>3.3. Design and Activity Verification of Novel Chalcone Derivatives</title><p>According to the contributions of the steric and electrostatic fields in the CoMFA model, the contribution of the steric field was greater than the contribution of electrostatic field. According to the analysis of the contour map, a relatively bulky substituent and electron-withdrawing substituent around R<sub>2</sub> position could increase the antitumor activity of chalcones. Then some new chalcone molecules were designed, as shown in <xref ref-type="table" rid="table3">Table 3</xref>.</p><p><xref ref-type="table" rid="table3">Table 3</xref>. Structure and predicted pIC<sub>50</sub> values of newly designed drug molecules with antitumor.</p><disp-formula id="scirp.91997-formula2"><graphic  xlink:href="//html.scirp.org/file/2-1710109x9.png"  xlink:type="simple"/></disp-formula><p><img src="//html.scirp.org/file/2-1710109x11.png" /><img src="//html.scirp.org/file/2-1710109x10.png" /></p><p>The pIC<sub>50</sub> value is larger, the antitumor activity of compounds is better. Finally, CoMFA model was used to predict the antitumor activity of new chalcones, then we found that the pIC<sub>50</sub> values of the designed structures (N1, N2, N4, N6) were 6.090, 6.101, 6.050 and 6.064 respectively, were better than other compounds’ pIC<sub>50</sub>, because these pIC<sub>50</sub> were bigger than the pIC<sub>50</sub> of some compounds in <xref ref-type="table" rid="table1">Table 1</xref>. The results proved that this model can provide useful indicators for further design of new drug.</p></sec></sec><sec id="s4"><title>4. Conclusion</title><p>In this paper, we divided the data of 24 chalcone derivatives into training set and test set, and then used the training set to establish the CoMFA model, used the test set to predict the antitumor activity. The result shows that the model had a good Q<sup>2</sup> and R<sup>2</sup> values of 0.6 and 0.997 respectively, which indicated that the model had higher predictive ability and stability. By analyzing the CoMFA contour maps, we found that the effects of the steric and electrostatic fields around the aligned molecules on their antitumor activity were proved. The designed new chalcone’s antitumor activity was calculated and their value was 6.090, 6.101, 6.050 and 6.064 respectively, which were better than the antitumor activity of other chalcone derivatives. Therefore, this model can be used as a tool for designing new chalcone and can improve the efficiency of molecular design.</p></sec><sec id="s5"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s6"><title>Cite this paper</title><p>Jiang, Y., Yang, Q. and Zhang, S.P. (2019) Computation of Structure Activity and Design of Chalcone Derivatives. Computational Chemistry, 7, 51-58. https://doi.org/10.4236/cc.2019.72004</p></sec></body><back><ref-list><title>References</title><ref id="scirp.91997-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Herencia, F., Luisa Ferrándiz, M. and Ubeda, A. (1998) Synthesis and Anti-Inflammatory Activity of Chalcone Derivative. Bioorganic and Medicinal Chemistry Letters, 8, 1169-1174. https://doi.org/10.1016/S0960-894X(98)00179-6</mixed-citation></ref><ref id="scirp.91997-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Dong, L.R., Hu, D.Y. and Wu, Z.X. (2017) Study of the Synthesis, Antiviral Bioactivity and Interaction Mechanisms of Novel Chalcone Derivatives that Contain the 1,1-Dichloropropene Moiety. Chinese Chemical Letters, 28, 1566-1570.  
https://doi.org/10.1016/j.cclet.2017.03.013</mixed-citation></ref><ref id="scirp.91997-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Jin, C., Liang, Y.J. and He, H. (2013) Synthesis and Antitumor Activity of Novel Chalcone Derivatives. Biomedicine &amp; Pharmacotherapy, 67, 215-217.  
https://doi.org/10.1016/j.biopha.2010.12.010</mixed-citation></ref><ref id="scirp.91997-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Mahapatra, D.K., Bharti, S.K. and Asati, V. (2015) Anti-Cancer Chalcones: Structural and Molecular Target Perspectives. European Journal of Medicinal Chemistry, 46, 69-114. https://doi.org/10.1016/j.ejmech.2015.05.004</mixed-citation></ref><ref id="scirp.91997-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Mohamed, M.F.A., Shaykoon, M.S.A. and Abdelrahman, M.H. (2017) Design, Synthesis, Docking Studies and Biological Evaluation of Novel Chalcone Derivatives as Potential Histone Deacetylase Inhibitors. Bioorganic Chemistry, 72, 32-41.  
https://doi.org/10.1016/j.bioorg.2017.03.005</mixed-citation></ref><ref id="scirp.91997-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Wang, H.-M., et al. (2015) Synthesis and Anti-Cancer Activity Evaluation of Novel Prenylated and Geranylated Chalcone Natural Products and Their Analogs. European Journal of Medicinal Chemistry, 92, 439-448.</mixed-citation></ref><ref id="scirp.91997-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Wang, G.C., Qiu, J., Xiao, X.W., et al. (2018) Synthesis, Biological Evaluation and Molecular Docking Studies of a New Series of Chalcones Containing Naphthalene Moiety as Anticancer Agents. Bioorganic Chemistry, 76, 249-257.  
https://doi.org/10.1016/j.bioorg.2017.11.017</mixed-citation></ref><ref id="scirp.91997-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Madhavi, S., Sreenivasulu, R. and Yazala, J.P. (2017) Synthesis of Chalcone Incorporated Quinazoline Derivatives as Anticancer Agents. Saudi Pharmaceutical Journal, 25, 275-279. https://doi.org/10.1016/j.jsps.2016.06.005</mixed-citation></ref><ref id="scirp.91997-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Cabral, B.L.S., Da Silva, A.C.G., de ávila, R.I., et al. (2017) A Novel Chalcone Derivative, LQFM064, Induces Breast Cancer Cells Death via p53, p21, KIT and PDGFRA. European Journal of Pharmaceutical Sciences.</mixed-citation></ref><ref id="scirp.91997-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Wang, L., Chen, G. and Lu, X. (2015) Novel Chalcone Derivatives as Hypoxia-Inducible Factor (HIF)-1 Inhibitor: Synthesis, Anti-Invasive and Anti-Angiogenic Properties. European Journal of Medicinal Chemistry, 89, 88-97.  
https://doi.org/10.1016/j.ejmech.2014.10.036</mixed-citation></ref><ref id="scirp.91997-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Ruiz, P., Ingale, K., Wheeler, J.S. and Mumtaz, M. (2016) 3D QSAR Studies of Hydroxylated Polychlorinated Biphenyls as Potential Xenoestrogens. Chemosphere, 144, 2238-2246. https://doi.org/10.1016/j.chemosphere.2015.11.004</mixed-citation></ref><ref id="scirp.91997-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Ghaleb, A., Aouidate, A. and Ghamali, M. (2017) 3D-QSAR Modeling and Molecular Docking Studies on a Series of 2,5 Disubstituted 1,3,4-Oxadiazoles. Journal of Molecular Structure, 1145, 278-284.</mixed-citation></ref><ref id="scirp.91997-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Bhatia, M.S., Pakhare, K.D. and Choudhari, P.B. (2012) Pharmacophore Modeling and 3D QSAR Studies of Aryl Amine Derivatives as Potential Lumazine Synthase Inhibitors. Arabian Journal of Chemistry, 10, S100-S104.</mixed-citation></ref><ref id="scirp.91997-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Zhi, H., et al. (2015) QSAR Studies on Triazole Derivatives as Sglt Inhibitors via CoMFA and CoMSIA. Journal of Molecular Structure, 1098, 199-205.  
https://doi.org/10.1016/j.molstruc.2015.06.004</mixed-citation></ref><ref id="scirp.91997-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Xin, Z. and Hui, Z. (2018) 3D-QSAR Studies on 1,2,4-Triazolyl 5-Azaspiro [2.4]-Heptanes as D3R Antagonists. Chemical Physics Letters, 704, 11-20.  
https://doi.org/10.1016/j.cplett.2018.05.022</mixed-citation></ref><ref id="scirp.91997-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Wang, Y., Xue, S. and Li, R. (2017) Synthesis and Biological Evaluation of Novel Synthetic Chalcone Derivatives as Anti-Tumor Agents Targeting Cat L and Cat K. Bioorganic &amp; Medicinal Chemistry, 26, 8. https://doi.org/10.1016/j.bmc.2017.09.019</mixed-citation></ref><ref id="scirp.91997-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Zhao, X., Chen, M.S., Huang, B.Y., et al. (2011) Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA) Studies on α1A-Adrenergic Receptor Antagonists Based on Pharmacophore Molecular Alignment. International Journal of Molecular Sciences, 12, 7022-7037.  
https://doi.org/10.3390/ijms12107022</mixed-citation></ref><ref id="scirp.91997-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Zhou, D., et al. (2014) Comparative Molecular Field Analysis (CoMFA) of Curcumin-Related Compounds for Anticancer Activity. Chinese Journal of Structural Chemistry, 33, 179-188.</mixed-citation></ref></ref-list></back></article>